What is Standard Biotools Inc (LAB) stock price today?

Standard Biotools Inc (LAB) currently trades at $0.93 per share. The stock has a market capitalization of $350.48M and a P/E ratio of —x.

Is LAB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Standard Biotools Inc has a Smart Value Score of 31/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Standard Biotools Inc's revenue and earnings?

Standard Biotools Inc has trailing twelve-month (TTM) revenue of $85.33M with profit margins of -87.80%. Earnings per share (EPS) is $-0.15.

LAB

Standard Biotools Inc

NASDAQ: LAB · HEALTHCARE · MEDICAL DEVICES

$0.93

+4.69% today

Updated 2026-04-30

Market cap

$350.48M

P/E ratio

—

P/S ratio

4.11x

EPS (TTM)

$-0.15

Dividend yield

—

52W range

$1 – $2

Volume

2.7M

Market cap

$350.48M

P/E ratio

—

P/S ratio

4.11x

EPS (TTM)

$-0.15

Dividend yield

—

52W range

$1 – $2

Volume

2.7M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

2.7

Growth

5.0

Quality

C+

2.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$1.55

+66.90%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at -87.80%

- Negative free cash flow $-1.67M

- Revenue declining -4.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$97.95M	$106.34M	$174.43M	$85.33M	$85.33M
Net income	$-190.10M	$-74.66M	$-138.88M	$-74.90M	$19.28M
EPS	—	—	—	—	$-0.15
Free cash flow	$-93.19M	$-46.12M	$-151.81M	$-82.65M	$-1.67M
Profit margin	-194.08%	-70.21%	-79.62%	-87.77%	-87.80%

Recent insider activity

Date	Insider	Type	Shares	Price
2026-04-06	KIM, HANJOON ALEX	Sale	70,183	—
2026-04-06	KIM, HANJOON ALEX	Buy	70,183	—
2026-04-06	KIM, HANJOON ALEX	Sale	21,301	$0.91

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
LAB	$350.48M	31	2.7	2.0	5.0	5.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Standard Biotools Inc trades at $0.93. Our Smart Value Score of 31/100 indicates the stock is weak. TTM revenue stands at $85.33M. with profit margins at -87.80%.

Frequently asked questions

What is Standard Biotools Inc's stock price?

Standard Biotools Inc (LAB) trades at $0.93.

Is Standard Biotools Inc overvalued?

Smart Value Score 31/100 (Grade F, Strong Sell).

What is the price target of Standard Biotools Inc (LAB)?

The analyst target price is $1.55, representing +66.9% upside from the current price of $0.93.

What is Standard Biotools Inc's revenue?

TTM revenue is $85.33M.

Company info

SectorHEALTHCARE

IndustryMEDICAL DEVICES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio4.11x

ROE-13.10%

Beta1.42

50D MA$0.99

200D MA$1.25

Shares out0.39B

Float0.22B

Short ratio—

Avg volume2.7M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

LAB vs LLY →LAB vs JNJ →LAB vs ABBV →Stock screener →